BioCentury
ARTICLE | Clinical News

Ketoconazole HRA regulatory update

October 13, 2014 7:00 AM UTC

EMA's CHMP recommended approval of oral ketoconazole HRA to treat endogenous Cushing's syndrome in patients ages >12 years. HRA Pharma expects a decision from the European Commission by year end, with...